#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14374	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2521	684.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	2043	2043	T	870	T,C	869,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14374	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2521	684.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1777	1777	C	889	C,G	887,2	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23994	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3999	748.2	0	.	n	.	0	T695C	SNP	695	695	T	1284	1284	C	943	C,G	941,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23994	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3999	748.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2560	2560	C	812	C,T	811,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23994	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3999	748.2	0	.	n	.	0	G2799A	SNP	2799	2799	G	3388	3388	A	875	A,C	874,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23994	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3999	748.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2634	2634	A	777	A	777	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23994	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3999	748.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	3186	3186	C	829	C,T	828,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23994	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3999	748.2	0	HET	.	.	.	C2058T,G	.	2058	2058	C	2647	2647	C	786	C,T,G	590,195,1	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	1904	folP	852	852	99.88	folP.l15.c4.ctg.1	2110	112.5	0	.	p	.	0	A204V	NONSYN	610	612	GCA	1137	1139	GTA	171;169;168	G;T;A	171;169;168	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	1904	folP	852	852	99.88	folP.l15.c4.ctg.1	2110	112.5	1	SNP	p	R228S	0	.	.	682	684	CGC	1209	1211	CGC	173;176;176	C;G;C	173;176;176	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4966	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3964	156.3	1	SNP	p	S91F	0	.	.	271	273	TCC	839	841	TCC	166;165;163	T;C;C	166;165;163	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4966	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3964	156.3	1	SNP	p	D95N	0	.	.	283	285	GAC	851	853	GAC	168;170;171	G;A,C;C,A	168;169,1;170,1	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4966	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3964	156.3	1	SNP	p	D95G	0	.	.	283	285	GAC	851	853	GAC	168;170;171	G;A,C;C,A	168;169,1;170,1	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	539	1826	mtrR	633	633	99.53	mtrR.l15.c4.ctg.1	1714	132.7	0	.	p	.	0	L15M	NONSYN	43	45	CTG	576	578	ATG	174;173;174	A;T;G	174;173;174	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1062	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1567	84.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4508	parC	2304	2304	99.65	parC.l6.c17.ctg.1	3599	156.4	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1913	1915	GCA	183;186;184	G;C,G;A	183;185,1;184	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4508	parC	2304	2304	99.65	parC.l6.c17.ctg.1	3599	156.4	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2396	2398	ATT	205;206;206	A;T;T	205;206;206	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4508	parC	2304	2304	99.65	parC.l6.c17.ctg.1	3599	156.4	0	.	p	.	0	V646A	NONSYN	1936	1938	GTG	2546	2548	GCG	208;207;208	G;C;G	208;207;208	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4508	parC	2304	2304	99.65	parC.l6.c17.ctg.1	3599	156.4	1	SNP	p	D86N	0	.	.	256	258	GAC	866	868	GAC	199;196;197	G;A,G;C	199;195,1;197	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4508	parC	2304	2304	99.65	parC.l6.c17.ctg.1	3599	156.4	1	SNP	p	S87W	0	.	.	259	261	AGT	869	871	AGT	199;204;204	A,C;G;T,C	198,1;204;203,1	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4508	parC	2304	2304	99.65	parC.l6.c17.ctg.1	3599	156.4	1	SNP	p	S87R	0	.	.	259	261	AGT	869	871	AGT	199;204;204	A,C;G;T,C	198,1;204;203,1	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4508	parC	2304	2304	99.65	parC.l6.c17.ctg.1	3599	156.4	1	SNP	p	S87I	0	.	.	259	261	AGT	869	871	AGT	199;204;204	A,C;G;T,C	198,1;204;203,1	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4508	parC	2304	2304	99.65	parC.l6.c17.ctg.1	3599	156.4	1	SNP	p	S88P	0	.	.	262	264	TCC	872	874	TCC	207;207;207	T,G;C;C,G	206,1;207;206,1	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4134	parE	1986	1986	99.9	parE.l6.c4.ctg.1	3164	163.0	0	.	p	.	0	V89A	NONSYN	265	267	GTC	843	845	GCC	224;223;222	G;C;C,T	224;223;221,1	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4134	parE	1986	1986	99.9	parE.l6.c4.ctg.1	3164	163.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1806	1808	GGC	223;221;220	G,T;G;C	222,1;221;220	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.1.001	penA.1.001	1	1	27	4010	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2879	173.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1504	1506	GCA	259;258;256	G,T;C;A	258,1;258;256	penA.1.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	4010	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2879	173.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1507	1509	ATC	254;255;255	A;T;C	254;255;255	penA.1.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	4010	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2879	173.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1519	1521	GTG	253;251;253	G;T;G	253;251;253	penA.1.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	4010	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2879	173.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1519	1521	GTG	253;251;253	G;T;G	253;251;253	penA.1.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	4010	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2879	173.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2023	2025	ACC	218;216;219	A,C;C,G;C	217,1;215,1;219	penA.1.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	4010	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2879	173.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2077	2079	GCG	191;190;190	G;C;G	191;190;190	penA.1.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	4010	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2879	173.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2077	2079	GCG	191;190;190	G;C;G	191;190;190	penA.1.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	4010	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2879	173.8	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2200	2202	GGC	207;208;207	G;G;C,T	207;208;206,1	penA.1.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	4010	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2879	173.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2209	2211	GGC	208;210;215	G;G;C	208;210;215	penA.1.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	4010	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2879	173.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2227	2229	CCG	227;230;231	C;C;G,C	227;230;230,1	penA.1.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	5578	ponA	2397	2397	99.92	ponA.l15.c4.ctg.1	3651	190.7	0	.	p	.	0	A375T	NONSYN	1123	1125	GCG	1774	1776	ACG	212;214;212	A;C;G	212;214;212	.	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	5578	ponA	2397	2397	99.92	ponA.l15.c4.ctg.1	3651	190.7	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1912	1914	CTG	241;242;240	C;T;G	241;242;240	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2146	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2366	113.1	0	.	p	.	0	S22G	NONSYN	64	66	AGC	610	612	GGC	128;128;130	G;G;C	128;128;130	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2146	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2366	113.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	792	792	C	158	C	158	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	346	porB1a	984	287	90.72	porB1a.l15.c30.ctg.1	1055	30.7	0	.	p	.	0	H217N	NONSYN	649	651	CAT	790	792	AAT	4;4;4	A;A;T	4;4;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	346	porB1a	984	287	90.72	porB1a.l15.c30.ctg.1	1055	30.7	0	.	p	.	0	D218N	NONSYN	652	654	GAT	793	795	AAT	4;4;4	A;A;T	4;4;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	346	porB1a	984	287	90.72	porB1a.l15.c30.ctg.1	1055	30.7	0	.	p	.	0	A222V	NONSYN	664	666	GCT	805	807	GTT	4;4;4	G;T;T	4;4;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	346	porB1a	984	287	90.72	porB1a.l15.c30.ctg.1	1055	30.7	0	.	p	.	0	V226A	NONSYN	676	678	GTA	817	819	GCA	4;4;4	G;C;A	4;4;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	346	porB1a	984	287	90.72	porB1a.l15.c30.ctg.1	1055	30.7	0	.	p	.	0	.	MULTIPLE	700	702	ACT	840	842	GTA	5;5;5	G;T;A	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	346	porB1a	984	287	90.72	porB1a.l15.c30.ctg.1	1055	30.7	0	.	p	.	0	N237fs	FSHIFT	709	709	A	849	849	A	2	A	2	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3084	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1807	208.5	0	.	p	.	0	T18M	NONSYN	52	54	ACG	501	503	ATG	261;259;257	A,C;T;G	260,1;259;257	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3084	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1807	208.5	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	876	878	CAA	256;256;258	C;A,C;A	256;255,1;258	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3084	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1807	208.5	0	.	p	.	0	E204K	NONSYN	610	612	GAA	1059	1061	AAA	243;241;240	A;A;A	243;241;240	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3084	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1807	208.5	0	.	p	.	0	E212D	NONSYN	634	636	GAA	1083	1085	GAT	216;216;215	G;A,G,C;T	216;214,1,1;215	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3084	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1807	208.5	0	.	p	.	0	H213D	NONSYN	637	639	CAT	1086	1088	GAT	215;215;215	G;A,T;T,G	215;214,1;214,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3084	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1807	208.5	0	.	p	.	0	V215A	NONSYN	643	645	GTT	1092	1094	GCT	213;214;216	G;C;T	213;214;216	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3084	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1807	208.5	0	.	p	.	0	S220T	NONSYN	658	660	AGC	1107	1109	ACT	215;215;217	A;C;T,G	215;215;216,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3084	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1807	208.5	0	.	p	.	0	R257M	NONSYN	769	771	AGG	1218	1220	ATG	293;293;298	A;T,A;G	293;292,1;298	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3084	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1807	208.5	0	.	p	.	0	R258S	NONSYN	772	774	AGG	1221	1223	AGC	298;303;301	A,C;G,C;C,G,A	297,1;302,1;299,1,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3084	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1807	208.5	0	.	p	.	0	A259G	NONSYN	775	777	GCT	1224	1226	GGT	304;304;302	G;G,T,C;T	304;302,1,1;302	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3084	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1807	208.5	1	SNP	p	G120K	0	.	.	358	360	GGC	807	809	GGC	241;242;246	G;G;C,T	241;242;245,1	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	10544	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5460	241.2	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2366	2368	CAT	269;268;271	C,A;A;T,G	268,1;268;270,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	1442	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1474	122.2	1	SNP	p	V57M	0	.	.	169	171	GTG	705	707	GTG	257;255;253	G;T;G	257;255;253	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
